This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background In patients with tricuspid regurgitation (TR), delayed surgical intervention is associated with poor outcomes, particularly in advanced stages. Methods This retrospective cohort study included 10 016 patients diagnosed with moderate to severe TR between 2008 and 2020.
Various factors can exacerbate disease progression in patients with HF and negatively impact treatment outcomes. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. ConclusionThe prevalence of poor HF treatment outcomes in Ethiopia was found to be high.
Organ perfusion pressure as a predictor of outcomes in cardiogenic shock: insights from the Altshock-2 registry. This study evaluated organ perfusion pressure (OPP), calculated as mean arterial pressure minus invasive central venous pressure, as a predictor of outcomes in CS. The primary outcome was in-hospital all-cause mortality.
Women and more deprived groups had lower rates of SAVR (age-standardised rates per 100 000 in 2020–2023: 17.07 Women were older; ethnic minority groups and those from most deprived areas were younger, with greater comorbidities. for men vs women; 9.82 for Index of Multiple Deprivation (IMD)-1 vs IMD-5) and TAVI (20.20
years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. From a pool of 37,011 patients, the study identified 2,360 patients under the age of 60 years who underwent these procedures, with 22% receiving TAVR and 78% SAVR.
We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self‐reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old.
AlloSure Heart, available for patients aged 15 years and older since 2020, is now clinically validated and commercially available for use in pediatric patients under 15, including infants. Short-term clinical outcomes and predicted cost savings of dd-cfDNA-led surveillance after pediatric heart transplantation. Clin Transplant.
Early diagnosis and prompt treatment of CHD contribute to enhanced neonatal outcomes and survival rates; however, there is a shortage of proficient examiners in remote regions. Articles were retrieved based on PRISMA Flow 2020 and inclusion and exclusion criteria.
BACKGROUND:Patient-reported outcome measures (PROMs) describe health status from the perspective of the patient. Using the trial’s primary publication and protocol, we abstracted key study characteristics including all primary and secondary outcome measures. Only 1 trial used a PROM as a primary outcome.
They concluded, "Our findings increase confidence in the normal automated GE Marquette 12 SL ECG software interpretation to predict a benign outcome. Smith comment: this is a very stupid outcome measure) What if we use that methodology for the ECG above? What is the gold standard for ECG interpretation: patient outcome!!!
The primary outcome was the ordinal 90-day modified Rankin Scale score (0, no symptoms, to 6, death).RESULTS:Among CONCLUSIONS:In patients with acute large infarcts, EVT was associated with improved functional outcomes compared with MM in patients with moderate stroke.
BackgroundRacial and ethnic minority groups are at a higher stroke risk and have poor poststroke outcomes. fold increase in reporting between 2010 and 2020. Trials were reviewed for availability of published results, data on race and ethnicity distribution, and trial characteristics. Overall, 60.1% White patients represented 65.0%
Outcome over process, in my view, works best here. 2020 Apr;16(4):223-237. Most people with high blood pressure will be treated with an ACE inhibitor, ARB, calcium channel blocker or a diuretic. There are others also. But in my view, what matters most is not the choice of medication but that the target blood pressure is achieved.
However, due to a presumed good disease outcome, fatality rates of SVT in adults (above 25 years) are yet to be explored.Aim:This study aims to shed light on the mortality trends of SVT in the adult population across the United States from 1999 to 2020.Methodology:The in adults (above 25 years) from 1999 to 2020. in 1999 to 0.5
LE involves significant risk, and patient demographics and outcome trends can inform clinical practice and patient management. Cardiovascular Implantable Electronic Device (CIED) extraction is necessary for patients with infected or malfunctioning leads.
BACKGROUND:Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic aneurysmal intervention, there is a paucity of literature aimed at understanding long-term disparities. The cumulative incidence of the primary outcome was 72.9% (95% CI, 71.8%73.9%)
Methods From January 2018 to December 2020, 947 patients with mitral valve surgery in our department were selected. The aim of the study is to investigate the impact of different time periods of surgery in the morning, afternoon and evening on the short-term and long-term results of mitral valve surgery.
We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. The primary outcome was 30-day mortality. Secondary outcomes included in-hospital and 30-day events. Secondary outcomes included in-hospital and 30-day events.
The overall prevalence of arrhythmias in pregnancy is estimated at 68-166 per 100,000 pregnancy-related admissions. Arrhythmias in pregnancy are thought to be multifactorial in nature due to a combination of hemodynamic, hormonal and autonomic changes that occur during pregnancy.
The aim of this study was to investigate the association of preoperative imaging and haemodynamic data derived from echocardiography (ECHO), cardiac magnetic resonance (CMR) and right heart catheterisation (RHC) with postoperative outcomes following TVS. The primary outcome was a composite of mortality and congestive heart failure at 1 year.
In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Methods Data from the 2020 California State Inpatient Database was used retrospectively. The odds of adverse outcomes such as mortality (aOR 3.90, 95% CI: 3.48–4.36), Mortality (43.2%
Methods:We analyzed data on Medicare fee-for-service beneficiaries aged ≥65 years hospitalized with AIS from April 1, 2020, to December 31, 2021. We used US Centers for Disease Control and Prevention’s 2020 Social Vulnerability Index (SVI) and compared demographic and clinical features by SVI tertiles (low 0-0.33, moderate 0.34-0.66,
Researchers analyze primary and secondary cardiovascular outcomes in 132,784 inpatients with COVID-19 (October 8, 2020 to September 30, 2021) and 31,173 inpatients with non-COVID-19 pneumonia (January 1, 2019 to December 31, 2019) in Korea. The results indicate a lower risk of cardiovascular disease in COVID-19 patients.
Methods Using an electronic medical record-based database with seven tertiary hospitals in Japan, this retrospective study included 7160 patients who underwent PCI between April 2014 and March 2020 and who completed a 3-year follow-up and were divided into three groups: no HF, HF with high BNP level and HF with low BNP level.
ABSTRACT Aims Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes and to assess implementation of guideline-recommended therapy in Europe and other ESC affiliated countries.
Patients and methods From December 2009 to June 2020, 388 elective patients were included in our retrospective study. Inverse probability of treatment weighting (IPTW) was used to adjust for selection bias and to estimate treatment effects on short- and long-term outcomes. vs. n = 30/8.0%, p = 0.012), fewer transfusions (0.93
We assessed outcomes following mitral valvular surgery in a tertiary referral centre with a dedicated mitral multi-disciplinary team (MDT). Between 2016 and 2020, 395 patients with mitral valvular disease were discussed at MDT. International guidelines recommend ‘heart teams’ as the preferred method for decision-making.
We aimed to compare in-hospital mortality and predictors in stroke patients with secondary rheumatological conditions.Methods:Using the National Inpatient Sample (NIS), we identified patients ≥18 admitted for stroke (Jan 2019 - Dec 2020), stratified into RA, SLE, scleroderma, or vasculitides groups using ICD-10-CM codes.
Objective To describe the impact of the pandemic on blood pressure screening and hypertension management based on a national quality of care scheme (Quality and Outcomes Framework, QOF) across key demographic, regional and clinical subgroups. million NHS patients registered at general practices (March 2019 to March 2023).
Since its first Food and Drug Administration (FDA) approval in 2016, there has been a significant uptrend in the utilization of leadless pacemakers (LL-PPM).
We present the cumulative percutaneous coronary intervention (PCI) data of all comers (stable angina and acute coronary syndromes [ACS]) who presented to Hadi Clinic between January 2018 and December 2020. A total of 567 patients underwent coronary catheterisation for the three-year period between January 2018 and December 2020.
Clinical outcomes in peripheral vascular disease have consistently been shown to benefit from accurate intravascular measurements, yet adoption has been limited by the additional procedure time and training required to interpret images" noted S. 2020 Mar;32(3):99-103. J Invasive Cardiol. 2 Yost, Mary L.,
CHD admissions remained stable from 2016 to 2020. Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020. Patients without CHD were older (mean age 71.5 years) and SV-CHD (mean age 17.9
Our study aims to describe the trends and outcomes of patients with Subarachnoid Hemorrhage (SAH) using a Nationwide Inpatient Sample (NIS) database.Methods:We examined the 2016-2020 NIS database, focusing on patients aged 18 years and older with a primary SAH discharge diagnosis.
The STS star rating system is one of the most sophisticated and highly regarded overall measures of quality in health care, rating the benchmarked outcomes of cardiothoracic surgery programs across the U.S. and Canada.
This study investigates clinical outcomes, aortic remodeling, and abdominal aortic perfusion patterns after TEVAR with the novel Castor device.MethodsFrom November 2020 to June 2023, 29 patients with TBAD involving the LSA were treated with the Castor single-branched stent graft.
We reported the feasibility and short-term outcomes of percutaneous transcatheter therapy with cerebral embolic protection. BACKGROUND:Surgery or fibrinolysis is the currently available evidence-based treatment for obstructive mechanical valve thrombus. The mean survival time free from death was 1101.48 (95% CI, 929.49–1273.47)
Although Impella or intra‐aortic balloon pump (IABP) is frequently used for left ventricular unloading (LVU) during VA‐ECMO treatment, there are limited data on comparative outcomes. The proportion of patients receiving Impella significantly increased from 2016 to 2020 (6.5% and 16.4%, respectively. versus 25.8%;P‐trend<0.001).
BACKGROUND:The aim of this study was to examine the impact of early versus delayed catheter-based therapies (CBTs) on clinical outcomes in patients with acute intermediate-risk pulmonary embolism (PE).METHODS:This Secondary outcomes included a composite of 30-day mortality, resuscitated cardiac arrest, and hemodynamic instability.
Background Despite improvements in outcomes of ST elevation myocardial infarction (STEMI), ventricular septal rupture (VSR) remains a known complication, carrying high mortality. Methods The National Inpatient Sample database (2009–2020) was used to study trends in admissions and outcomes of post-STEMI VSR over time. and 10 ± 1.2%
Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiac arrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel. to 0.08; p = 0.21). to 1.07; p = 0.24).
Introduction:The outcomes of endovascular thrombectomy (EVT) in SARS-CoV2 positive patients with acute ischemic stroke (AIS) are not well studied. Temporal analyses compared outcomes across the years 2020-2022.Results:A Stroke, Volume 55, Issue Suppl_1 , Page ATP203-ATP203, February 1, 2024.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content